Respiratory Infections News

The CDC on Thursday recommended updated COVID-19 vaccines for the 2024-2025 respiratory season, and a newly approved 21-valent pneumococcal conjugate vaccine for adults.

The CDC’s vaccine advisors voted unanimously Wednesday to recommend that everyone aged 75 years or older get vaccinated against respiratory syncytial virus.

The odds for symptom resolution after a 14-day antibiotic treatment for nonsevere exacerbation of bronchiectasis increased among Indigenous children and children with low cough scores, according to results published in CHEST.

Greater adherence to the planetary health diet was associated with a lower risk for an early death from several causes and produced a significantly lower environmental impact, a study showed.

Moderna announced positive phase 3 trial data for its combination COVID-19 and influenza vaccine this week, suggesting a combination shot for respiratory infections is on the way.

SAN DIEGO — Amikacin for 6 months improved respiratory symptoms in adults with newly diagnosed or recurrent Mycobacterium avium complex lung disease, according to a presentation at the American Thoracic Society International Conference.

Among patients with non-cystic fibrosis bronchiectasis, once-daily brensocatib for 52 weeks lowered the annualized pulmonary exacerbation rate and was well tolerated, according to topline results from the ASPEN trial.

A second dairy worker in Michigan became the third human case of highly pathogenic avian influenza virus linked to an outbreak in dairy cows, the CDC announced Thursday.

A recent survey showed that only about one-quarter of older adults have received respiratory syncytial virus vaccinations.

Interleukin-17 and IL-23 inhibitors do not increase the risk for tuberculosis reactivation among patients with psoriatic disease who have a latent tuberculosis infection, according to a retrospective study.